244 related articles for article (PubMed ID: 31355931)
21. Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
Garcia HH; Del Brutto OH;
Epilepsy Behav; 2017 Nov; 76():158-162. PubMed ID: 28606690
[TBL] [Abstract][Full Text] [Related]
22. Controversies in the treatment of seizures associated with neurocysticercosis.
Singh G; Sharma R
Epilepsy Behav; 2017 Nov; 76():163-167. PubMed ID: 28673685
[TBL] [Abstract][Full Text] [Related]
23. Anthelmintics for people with neurocysticercosis.
Abba K; Ramaratnam S; Ranganathan LN
Cochrane Database Syst Rev; 2010 Jan; (1):CD000215. PubMed ID: 20091504
[TBL] [Abstract][Full Text] [Related]
24. The relationship between neurocysticercosis and epilepsy: an endless debate.
Carpio A; Romo ML
Arq Neuropsiquiatr; 2014 May; 72(5):383-90. PubMed ID: 24863516
[TBL] [Abstract][Full Text] [Related]
25. T2 relaxometry helps prognosticate seizure outcome in patients with solitary cerebral cysticercosis.
de Souza A; Nalini A; Saini J; Thennarasu K
J Neurol Sci; 2017 May; 376():1-6. PubMed ID: 28431589
[TBL] [Abstract][Full Text] [Related]
26. Anthelmintics for people with neurocysticercosis.
Abba K; Ramaratnam S; Ranganathan LN
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD000215. PubMed ID: 20238309
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
Del Brutto OH; Roos KL; Coffey CS; García HH
Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Long-Term Outcomes Between 7 Days and 28 Days Albendazole Monotherapy in the Treatment of Single-Lesion Neurocysticercosis in Children.
Johnson N; Saini AG; Malhi P; Khandelwal N; Singhi P
J Child Neurol; 2022 Jan; 37(1):28-34. PubMed ID: 34641721
[TBL] [Abstract][Full Text] [Related]
29. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis.
Carpio A; Hauser WA
Neurology; 2002 Dec; 59(11):1730-4. PubMed ID: 12473760
[TBL] [Abstract][Full Text] [Related]
30. Seizure outcome in patients with a solitary cerebral cysticercus granuloma.
Rajshekhar V; Jeyaseelan L
Neurology; 2004 Jun; 62(12):2236-40. PubMed ID: 15210888
[TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of lesion load and efficacy of 3 cycles of albendazole in disseminated cysticercosis: a prospective evaluation.
Pandey S; Malhotra HS; Garg RK; Malhotra KP; Kumar N; Rizvi I; Jain A; Kohli N; Verma R; Sharma P; Uniyal R; Pandey S
BMC Infect Dis; 2020 Mar; 20(1):220. PubMed ID: 32171260
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study.
Stelzle D; Makasi C; Schmidt V; Trevisan C; Van Damme I; Ruether C; Dorny P; Magnussen P; Zulu G; Mwape KE; Bottieau E; Prazeres da Costa C; Prodjinotho UF; Carabin H; Jackson E; Fleury A; Gabriël S; Ngowi BJ; Winkler AS
Infection; 2023 Aug; 51(4):1127-1139. PubMed ID: 36961623
[TBL] [Abstract][Full Text] [Related]
33. Radiographic Improvement of Larval Cysts in Neurocysticercosis.
Landzberg DR; Dhir A; Jillella DV
Ann Neurol; 2021 Feb; 89(2):416-417. PubMed ID: 33051897
[No Abstract] [Full Text] [Related]
34. Natural history of solitary cerebral cysticercosis on serial magnetic resonance imaging and the effect of albendazole therapy on its evolution.
de Souza A; Nalini A; Kovoor JM; Yeshraj G; Siddalingaiah HS; Thennarasu K
J Neurol Sci; 2010 Jan; 288(1-2):135-41. PubMed ID: 19875133
[TBL] [Abstract][Full Text] [Related]
35. Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis.
Otte WM; Singla M; Sander JW; Singh G
Neurology; 2013 Jan; 80(2):152-62. PubMed ID: 23269591
[TBL] [Abstract][Full Text] [Related]
36. One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial.
Singhi P; Dayal D; Khandelwal N
Pediatr Infect Dis J; 2003 Mar; 22(3):268-72. PubMed ID: 12634590
[TBL] [Abstract][Full Text] [Related]
37. Fourteen Days vs 28 Days of Albendazole Therapy for Neurocysticercosis in Children: An Open Label Randomized Controlled Trial.
Singla A; Lekhwani S; Vaswani ND; Kaushik JS; Dabla S
Indian Pediatr; 2022 Dec; 59(12):916-919. PubMed ID: 36333896
[TBL] [Abstract][Full Text] [Related]
38. Does albendazole affect seizure remission and computed tomography response in children with neurocysticercosis? A Systematic review and meta-analysis.
Mazumdar M; Pandharipande P; Poduri A
J Child Neurol; 2007 Feb; 22(2):135-42. PubMed ID: 17621473
[TBL] [Abstract][Full Text] [Related]
39. Cysticidal therapy: impact on seizure control in epilepsy associated with neurocysticercosis.
Santos IC; Kobayashi E; Cardoso TM; Guerreiro CA; Cendes F
Arq Neuropsiquiatr; 2000 Dec; 58(4):1014-20. PubMed ID: 11105066
[TBL] [Abstract][Full Text] [Related]
40. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
Romo ML; Carpio A; Kelvin EA
J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
